Jennifer M. Dolan

Array ( [id] => 4669324 [patent_doc_number] => 20080044384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Recombinant Human Cytomegalovirus And Vaccines Comprising Heterologous Antigens' [patent_app_type] => utility [patent_app_number] => 11/571081 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15772 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044384.pdf [firstpage_image] =>[orig_patent_app_number] => 11571081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 216808 [patent_doc_number] => 07611717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Identifying virally infected and vaccinated organisms' [patent_app_type] => utility [patent_app_number] => 11/155830 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 51 [patent_no_of_words] => 25995 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611717.pdf [firstpage_image] =>[orig_patent_app_number] => 11155830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101867 [patent_doc_number] => 07722878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'PRRSV subunit vaccines' [patent_app_type] => utility [patent_app_number] => 11/154617 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7600 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/722/07722878.pdf [firstpage_image] =>[orig_patent_app_number] => 11154617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840143 [patent_doc_number] => 07390487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Chimeric human papillomavirus (HPV) L1 molecules and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/154791 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12354 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390487.pdf [firstpage_image] =>[orig_patent_app_number] => 11154791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019280 [patent_doc_number] => 20050221299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Peptide from the glycoprotein B from human herpesvirus 7 for use in a serological ELISA test' [patent_app_type] => utility [patent_app_number] => 11/134305 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4146 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221299.pdf [firstpage_image] =>[orig_patent_app_number] => 11134305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111028 [patent_doc_number] => 20050208483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Kits for detecting anti-sirs antibodies' [patent_app_type] => utility [patent_app_number] => 11/127491 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12864 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208483.pdf [firstpage_image] =>[orig_patent_app_number] => 11127491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168497 [patent_doc_number] => 20050202045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Recombinant avian herpesvirus useful in vaccine production' [patent_app_type] => utility [patent_app_number] => 11/126465 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11159 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202045.pdf [firstpage_image] =>[orig_patent_app_number] => 11126465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 386512 [patent_doc_number] => 07303881 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => 'Antigen delivery compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/121840 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 26 [patent_no_of_words] => 13854 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/303/07303881.pdf [firstpage_image] =>[orig_patent_app_number] => 11121840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977836 [patent_doc_number] => 20050287554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Regions of papilloma virus E1 helicase involved in E1 oligomerization' [patent_app_type] => utility [patent_app_number] => 11/112784 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17202 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287554.pdf [firstpage_image] =>[orig_patent_app_number] => 11112784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050337 [patent_doc_number] => 20050186224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Attenuated bovine respiratory syncytial virus' [patent_app_type] => utility [patent_app_number] => 11/112261 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9171 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186224.pdf [firstpage_image] =>[orig_patent_app_number] => 11112261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880530 [patent_doc_number] => 20060029612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Prevention and treatment of recurrent respiratory papillomatosis' [patent_app_type] => utility [patent_app_number] => 11/107575 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13554 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029612.pdf [firstpage_image] =>[orig_patent_app_number] => 11107575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 499850 [patent_doc_number] => RE039544 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-04-03 [patent_title] => 'Viral obesity methods and compositions' [patent_app_type] => reissue [patent_app_number] => 11/099679 [patent_app_country] => US [patent_app_date] => 2005-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5328 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039544.pdf [firstpage_image] =>[orig_patent_app_number] => 11099679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177751 [patent_doc_number] => 07655459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Enhancer of anticancer activity in viral therapy and method of preventing or treating cancer' [patent_app_type] => utility [patent_app_number] => 10/594964 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8228 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655459.pdf [firstpage_image] =>[orig_patent_app_number] => 10594964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069048 [patent_doc_number] => 20050244431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Recombinant herpesvirus and polyvalent vaccine' [patent_app_type] => utility [patent_app_number] => 11/092838 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6250 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244431.pdf [firstpage_image] =>[orig_patent_app_number] => 11092838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 863902 [patent_doc_number] => 07368116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Method of enhancing a targeted immune response against tumors' [patent_app_type] => utility [patent_app_number] => 11/090686 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 16678 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368116.pdf [firstpage_image] =>[orig_patent_app_number] => 11090686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219248 [patent_doc_number] => 20050260566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Methods and compositions for the detection of cervical disease' [patent_app_type] => utility [patent_app_number] => 11/087227 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31036 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260566.pdf [firstpage_image] =>[orig_patent_app_number] => 11087227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069050 [patent_doc_number] => 20050244433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Treatment of papillomavirus infections' [patent_app_type] => utility [patent_app_number] => 11/079525 [patent_app_country] => US [patent_app_date] => 2005-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6987 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244433.pdf [firstpage_image] =>[orig_patent_app_number] => 11079525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250043 [patent_doc_number] => 20050142115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Papilloma pseudovirus and preparation' [patent_app_type] => utility [patent_app_number] => 11/060034 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1306 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142115.pdf [firstpage_image] =>[orig_patent_app_number] => 11060034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 80725 [patent_doc_number] => 07744903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Immunological herpes simplex virus antigens and methods for use thereof' [patent_app_type] => utility [patent_app_number] => 11/055477 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 19418 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/744/07744903.pdf [firstpage_image] =>[orig_patent_app_number] => 11055477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5642297 [patent_doc_number] => 20060280752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Peptide epitope-based vaccine for treating Herpes Simplex Virus infections and related diseases' [patent_app_type] => utility [patent_app_number] => 11/039578 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8011 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20060280752.pdf [firstpage_image] =>[orig_patent_app_number] => 11039578 [rel_patent_id] =>[rel_patent_doc_number] =>)